Liu et al., demonstrated that small interference RNA (siRNA)-induced silencing of SphK2 inhibited NSCLC cell proliferation and chemo-sensitized NSCLC cells to gefitinib-induced apoptosis [16]. This evidence concerns the gene SPHK2 and non-small cell lung carcinoma.